Introduction
Iron is a component of many metalloproteins and plays a crucial role in a range of vital biochemical activities, such as oxygen sensing and transport, electron transfer, and catalysis [1] . When present in excess, cellular iron overload leads to toxicity and cell death via free radical formation and lipid peroxidation [2] . Non-transferrin bound iron (NTBI), and labile plasma iron (LPI) are toxic forms of the iron that appear in plasma when the transferrin saturation increases. Changes in the labile iron pool (LIP) can be considered a cytosolic equivalent of plasma NTBI influence on intracellular ferritin (Ft) levels [3] . Thus, elevated levels of the LIP lead to an increased accumulation of Ft iron and in extreme cases to the formation of hemosiderin [4] . Iron chelation therapy is required to prevent iron-mediated injury to cells and to reduce the levels of NTBI, LPI, LIP and plasma Ft [5, 6] .
At present, the treatment of iron overload diseases especially in β-thalassemia patients commonly involves the administration of deferiprone (DFP), desferioxamine (DFO) and deferasirox (DFX) [7] [8] [9] . Effectiveness, cost, compliance, quality of life and side effects of the chelators are all relevant considerations. Many adverse effects of these chelators include: nausea, vomiting, gastrointestinal tract disturbance, leukocytopenia, thrombocytopenia, arthopathy, zinc deficiency and agranulocytosis from DFP, skin redness, local irritation, mild pain at the applied sites from DFO, renal toxicity, Fanconi syndrome, formation of rashes and gastrointestinal tract disturbance from DFX [10] .
We have been studying the properties of a specific novel orally active iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1). Our previous studies have illustrated that the CM1 (MW=256, K part =0.53) is an effective bidentate chelator and is slightly more lipophilic than the DFP (MW=139, K part =0.11) [11] . Preliminary results have established that CM1 is relative non-toxic in acute studies and can reduce the levels of malondialdehyde (MDA), LIP and reactive oxygen species in both mouse primary hepatocytes and human hepatocellular carcinoma (HepG2) cells [12, 13] . Furthermore, CM1 was found not to be toxic to the peripheral blood mononuclear cells and liver cells of β-thalassemia mice under normal and iron overload conditions after 240 d exposure [14] . Srichairatanakool et al. [15] reported that CM1 removed excess iron in the blood compartment and tissues of iron loaded wild type C57BL/6 mice. These preliminary studies have now been extended to include β-thalassemic mice.
Materials and methods

Animals
The heterozygous β-thalassemia knockout (BKO, mu β th-3/+ ) mice strain C57BL/6 aged between 6-10 weeks and having a body weight (20±5) g were kindly supplied by the Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Thailand [16] . The animals were housed in polyethylene cages and maintained in a clean airconditioned room under the controlled conditions of 12-h day/12-h night cycle at (25±3) °C and at 40%-70% humidity. The study protocol that was used has been approved by the Animal Ethical Committee of the Medical Faculty, Chiang Mai University, Thailand (Reference Number -3/2554).
Iron overload in mice and chelation treatment
The mice were fed a normal pellet diet (N diet) and an N diet supplemented with 0.2% (w/w) ferrocene (Fe diet) to induce iron overload, over 240 d [17] . The iron-loaded mice were randomly subdivided into 5 groups. The [18] . The control group was fed with N diet throughout the study. Blood samples were collected from the tail vein and collected into Na-heparin tubes. Plasma was separated immediately and kept frozen -20 °C for further analysis.
Quantification of plasma NTBI
Plasma NTBI was quantified based on nitrilotriacetic acid (NTA) chelation/HPLC technique with slight modifications [19] . Briefly, plasma was incubated with a weak chelator; NTA solution (80 mmol/L, at final concentration, pH 7.0) for 30 min at room temperature to produce the Fe 3+ -(NTA) 2 complex from NTBI. Subsequently, the complex was filtered through a membrane (Nano-Sep ® , 10-kDa cutoff, polysulfone type; Pall Life Sciences, Ann Arbor, MI, USA) at 12 000 r/min for 60 min and analyzed using a non-metallic HPLC system. NTBI was fractionated on a glass analytical column (ChromSep-ODS1, 100 mm 伊 3.0 mm, 5 μm), eluted with a mobile phase solvent (3 mmol/L CP22 in 20% acetonitrile/MOPS pH 7.0) at a flow rate of 1.0 mL/min and the optical density (OD) was monitored at 450 nm using a flow cell detector (SpecMonitor 2300; LDC Milton-Roy Inc., Riviera Beach, FL, USA). Data analysis was conducted with BDS software (BarSpec Ltd., Rehovot, Israel). NTBI concentration represented by Fe 3+ -(CP22) 3 peak area was calculated with a calibration curve constructed from Fe
Quantification of LPI
In principle, redox-active LPI can convert non-fluorescent dihydrorhodamine (DHR) to oxidized form rhodamine (R), resulting in an increase of fluorescence intensity (FI) [20] . In the assay, plasma was incubated with/without 5 mmol/L DFP at 37 °C for 30 min and then the DHR solution containing ascorbic acid was added. Kinetics of increasing FI was followed immediately for 40 min, with readings every 2 min at 37 °C using a 96-well plate spectrofluorometer (λ excitation 485 nm, λ emission 538 nm). The slope of the FI was plotted against a reaction time of between 15-40 min. A calibration curve was constructed from the standard ferrous ammonium sulfate solution (0-20 μmol/L). Difference in rate of DHR oxidation represents a component of redox active LPI. The LPI concentration was calculated from the calibration curve relating the differences in slope with/without DFP versus the standard iron concentration as described [15] .
Measurement of plasma ferritin concentration
Ft concentration was determined by sandwich ELISA method as described by the manufacturer (Abnova, United Kingdom). Briefly, plasma was reacted with the solid phase-immobilized anti-Ft antibodies at room temperature for 60 min. After the removal of unbound proteins by being washed four times, anti-Ft antibodies conjugated with horseradish peroxidase was added to the plasma solution to form a complex with the previously bound Ft and it was then incubated at room temperature for 10 min. Following the washing, the enzyme bound to the immunosorbent was assayed by the addition of a chromogenic substrate, 3,3',5,5'-tetramethylbenzidine and incubated in the dark for 10 min. The quantity of the bound enzyme was proportional to the concentration of Ft in the sample. Thus, the absorbance was determined at 450 nm.
Assessment of plasma lipid peroxidation
MDA was adopted as an index of lipid peroxidation and was determined in plasma using the HPLC-based thiobarbituric acid reactive substance (TBARS) method [21] . Plasma was mixed with the reaction mixture; 10% (w/v) trichloroacetic acid containing 50 mg/L butylated hydroxytoluene and heated at 90 °C for 30 min. After centrifugation (10 000 r/mim, 10 min), the supernatant was mixed with the chromogenic solution containing 0.44 mol/L H 3 PO 4 and 0.6% (w/v) thiobarbituric acid (TBA). The mixture was heated to 90 °C for 30 min to produce a pink-colored product represented as TBARS. In the HPLC analysis [21] the product was subsequently fractionated on the column (ZORBAX Eclipse XDB-C18, 150 mm 伊 4.6 mm, 5 μm, Agilent Technologies), eluted with a mobile-phase solvent of 50 mmol/L KH 2 PO 4 pH 7.0 : methanol (65:35, v/v) at a flow rate of 1.0 mL/min and detected at 532 nm. Finally, TBARS concentrations were determined from the standard curve constructed by varied concentrations of 1,1,3,3-tetramethoxypropane (0-100 μmol/L).
Statistical analysis
Data were presented as mean±SEM. Statistical significance was determined using One-way analysis of variance (ANOVA), in which P<0.05 was considered significant.
Results
Plasma NTBI concentration
Low levels of NTBI were detected in the plasma of N diet-fed BKO mice (2.1±0.78) μmol/L. In contrast, the NTBI concentration was significantly increased in the plasma of the BKO mice fed with Fe diet for 240 d (28.9±4.33) μmol/ L, indicating iron overload ( Figure 1 ). As expected, the increase of NTBI concentration was reduced as a result of treatment with DFP (50 mg/kg) and CM1 (50 mg/kg) (P<0.005). Surprisingly, the levels of plasma NTBI in the mice after intervention with CM1 (100 mg/kg) were found to be higher than the value resulting with 50 mg/kg. 
Plasma LPI level
Plasma LPI was not detected in N diet-fed BKO mice (Figure 2) . However, the Fe diet induced the formation of LPI in plasma of mice, when mice were fed with the high Fe diet, generating a value of 15 μmol/L after 8 months. After chelation with DFP and CM1 at concentration of 50 mg/kg for 6 months, both chelators were found to be effective in lowering the plasma LPI levels in Fe-fed BKO 
Discussion
Iron is an essential cofactor in a variety of cellular processes. However, iron in excess is toxic because of its propensity to induce the formation of dangerous free radicals, leading to mitochondrial dysfunctions and cell death via oxidative damage of biomolecules and lipid peroxidation [22] [23] [24] . Enhanced lipid peroxidation and hepatocellular injury have been proposed as an initial step by which iron causes cellular injury [25, 26] . NTBI is the circulating forms of iron that are not tightly bound to plasma transferrin of thalassemia and sickle cell anemia patients [27, 28] . LPI represents a component of NTBI that is redox-active and capable of permeating into organs and inducing tissue iron overload [29] . NTBI is cleared rapidly from plasma by the liver via the transmembrane protein Zrt-and Irt-like protein 14 (Zip14) [30] and is likely to play an important role in hepatocyte iron loading in hereditary hemochromatosis and other iron overload conditions especially in β-thalassemia. Both NTBI and LPI appear primarily in heavily transfused β-thalassemia patients [5, 31, 32] .
In order to investigate problems associated with iron overload tissue, several animal models have been developed. Thus duodenal iron absorption by β-thalassemic mice are found to be modestly increased due to low hepcidin level and enhanced mucosal iron uptake, leading to a sustained iron overload [33] [34] [35] . Liver 25-amino acid hepcidin controls influx of dietary iron from duodenum to plasma and efflux of heme-derived iron from macrophages through degradation of the cellular iron exporter called ferroportin [36] . Interestingly, patients with myelodysplastic syndrome and iron overload showed an increase in serum levels of hepcidin related to their iron and oxidative stress status after 3-month treatment with DFX [37] . In addition, serum level of growth differentiation factor 15 which involves in hepcidin regulation can be induced in normal subjects after iron chelation treatment [38] . Another useful animal model is that of ferrocene-loaded rats, which has been used to examine the efficacy of iron chelators [39, 40] .
In this study we decided to iron load β-thalassemic mice with ferrocene. Long-term ferrocene administration induced iron overload in our experimental mice as determined by the significant increase of NTBI, LPI and Ft levels in the plasma. The iron loaded mice behaved normally for the duration of the study and showed the same weight gain as control animals. Chelation treatment with either DFP or CM1 led to the reduction of NTBI and LPI levels in β-thalassemic mice. At the higher concentration of 100 mg/kg, CM1 was found to be less effective than when present at a concentration of 50 mg/kg. This is surprising, but may be related to the toxicity of CM1 at the higher dose. Both DFP and CM1 were found to be effective at reducing MDA concentrations and this activity is almost certainly associated with their iron chelating ability. Interestingly, CM1 again was found to be more effective at 50 mg/kg than at 100 mg/kg. In contrast to the findings related to NTBI, serum Ft levels were found to be unaffected by the presence of chelators. This finding reflects the observation that in some cases in β-thalassemia patients treated with iron chelators, the plasma Ft levels are largely unchanged or are only reduced after prolonged iron chelator treatment.
In conclusions, CM1 is an effective orally iron chelator and demonstrates marked iron chelating properties under biological conditions. It also reduces iron-induced lipid peroxidation in chronic iron overloaded β-thalassemic mice. Whether these beneficial effects can be translated to the treatment of thalassemia patients remains to be established.
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Comments
Background
Iron overload leads to toxicity and cell death as free iron can be induced by Fenton reaction to form free radicals. Current clinical drugs for treating iron overload in β-thalassaemia include DFP, DFX and DFO, all having various side effects.
Research frontiers
The present research work describes that the iron chelator CM1 can effectively reduce non-transferrin-bound iron, LPI and MDA level in the plasma of iron overloaded mice, but not ferritin content.
Related reports
The data presented in this article showed that CM1 (100 mg/kg) has no effect on the reduction of NTBI, LPI and MDA of plasma in iron overload mice whereas in other papers, increase of CM1 dose leads to a gradual iron removal in mouse primary hepatocytes and human hepatocellular carcinoma cells (Kulprachakarn et al. 2013 ).
Innovations and breakthroughs
Data has showed that CM1 at 50 mg/kg is effective to reduce NTBI, LPI and MDA level in the plasma of iron overload but not at 100 mg/kg. At both doses, CM1 does not change serum ferritin level.
Applications
The article describes that CM1 is an effective iron chelator to remove iron in β-thalassaemia mice and reduce ironinduced lipid peroxidation. Combined with other studies on CM1, the compound may be applicable to β-thalassaemia patients.
Peer review
This manuscript has evaluated that CM1 on the iron removal capacity and lipid peroxidation in long-term iron loaded β-thalassaemia mice before translating the compound to the β-thalassaemia patients, which is very common in southeast Asia. The results are interesting.
